Desk› Healthcare› Themis Medicare Ltd

Themis Medicare Ltd

BSE 530199 THEMISMED INE083B01024

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

21 filings · 6 material · busiest 2026-08-13

What it files

SAST7 General3 KMP2 Investor Presentation2 Newspaper Publication1 Board Outcome1 Results1 Board Meeting1

Filings

21 in the window

17 August 2026

General

Change Of Company Secretary / Compliance Officer's E-Mail ID And Updation Of E-Mail Id Of RTA,

Please refer to our Intimation of change/updation in Email ID of Company Secretary and RTA.

Company Update / General View filing →
14 August 2026

Newspaper Publication

Newspaper Publication

Newspaper Publication of Un-audited Financial Results for the quarter ended 30th June, 2026

Company Update / Newspaper Publication View filing →
13 August 2026

Board Outcome

Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th August 2026.

Please refer to the outcome of the Board Meeting held on 13th August 2026.

Board Meeting / Outcome of Board Meeting View filing →
13 August 2026

Results

Results- Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2026.

Kindly refer to the attachment.

Result / Financial Results View filing →
13 August 2026

KMP

Appointment of Company Secretary and Compliance Officer

Please refer to the intimation of appointment of Company Secretary & Compliance Officer and Key Managerial Personnel of the Company.

Company Update / Appointment of Company Secretary / Compliance Officer View filing →
13 August 2026

KMP

Resignation of Company Secretary / Compliance Officer

Please refer to the attachment.

Company Update / Resignation of Company Secretary / Compliance Officer View filing →
13 August 2026

General

Announcement Under Regulation 30(5) Of SEBI (LODR)- Updates

Please refer to the attachment.

Company Update / General View filing →
13 August 2026

Investor Presentation

Investor Presentation

Investors Presentation for the quarter ended 30.06.2026

Company Update / Investor Presentation View filing →
13 August 2026

Investor Presentation

Investor Presentation

Investors Presentation for the quarter ended 30.06.2026

Company Update / Investor Presentation View filing →
5 August 2026

SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
31 July 2026

SAST

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 30, 2026 for Vividhmargi Investments Pvt Ltd

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
31 July 2026

Board Meeting

Board Meeting Intimation for Approval Of Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended On 30Th June, 2026 And Limited Review Reports Of The Statutory Auditors Thereon

Themis Medicare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....

Board Meeting / Board Meeting View filing →
21 July 2026

SAST

Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Vividhmargi ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
21 July 2026

SAST

Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 21, 2026 for Vividhmargi Trust

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
21 July 2026

SAST

Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
17 July 2026

SAST

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Vividhmargi Investments Pvt Ltd

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
8 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please refer to the RTA Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
2 July 2026

SAST

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd

Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
25 June 2026

Trading Window

Closure of Trading Window

Intimation of Closure of Trading Window.

Insider Trading / SAST / Closure of Trading Window View filing →
23 June 2026

Clarification

Clarification sought from Themis Medicare Ltd

The Exchange has sought clarification from Themis Medicare Ltd on June 23, 2026, with reference to Movement in Volume. The reply is awaited.

Company Update / Clarification
23 June 2026

General

Clarification On Volume Movement

Please refer to the attachment.

Company Update / General View filing →